Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemically modified capsular polysaccharides as vaccines.

H J Jennings1

  • 1Division of Biological Sciences, National Research Council of Canada, Ottawa, Ontario.

Advances in Experimental Medicine and Biology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The conformational epitope of type III group B Streptococcus capsular polysaccharide.

Advances in experimental medicine and biology·2003
Same author

NMR and molecular modeling of complex carbohydrates and carbohydrate-protein interactions. Applications to anti-bacteria vaccines.

Advances in experimental medicine and biology·2003
Same author

Multifunctionalized alpha,beta-cyclopentenones from C-2 and C-4-ulopyranosyl compounds: a stereospecific rearrangement initiated by base.

Carbohydrate research·2001
Same author

Construction of multivalent sialyl Le(x) from the type Ia group B Streptococcus capsular polysaccharide.

Carbohydrate research·2001
Same author

Immunostimulant oxidized beta-glucan conjugates.

International immunopharmacology·2001
Same author

Biochemical engineering of surface alpha 2-8 polysialic acid for immunotargeting tumor cells.

The Journal of biological chemistry·2000

Researchers developed new synthetic antigens to improve bacterial vaccines. Conjugating polysaccharides to tetanus toxoid enhanced immune responses, creating potential infant vaccine candidates against bacterial meningitis.

Area of Science:

  • Immunology
  • Vaccine Development
  • Bacterial Polysaccharides

Background:

  • Capsular polysaccharides are crucial for bacterial vaccines.
  • Challenges exist in vaccine efficacy, particularly for infants and specific bacterial strains.
  • Meningococcal polysaccharides present unique immunogenicity issues.

Purpose of the Study:

  • To address poor immunogenicity of meningococcal A, B, and C polysaccharides.
  • To propose solutions using artificial synthetic antigens for enhanced vaccine development.
  • To explore chemical modifications for improved immune response.

Main Methods:

  • Conjugation of polysaccharides (A and C) to tetanus toxoid.
  • Chemical modification (N-propionylation) of polysaccharide B.

Related Experiment Videos

  • Assessment of immunogenicity in mouse models.
  • Utilizing Nuclear Magnetic Resonance (NMR) spectroscopy for structural analysis.

    • Main Results:

    • Conjugation of A and C polysaccharides to tetanus toxoid created T-cell dependent antigens, showing potential for infant vaccines.
    • Direct conjugation of polysaccharide B to tetanus toxoid had limited success in enhancing immunogenicity.
    • N-propionylation of polysaccharide B followed by conjugation induced high titers of cross-reactive IgG antibodies in mice.

    Conclusions:

    • Artificial synthetic antigens offer a promising strategy for improving polysaccharide-based vaccines.
    • Chemical modification of bacterial polysaccharides can overcome immunogenicity barriers.
    • Understanding structure-immunospecificity relationships is key for designing effective vaccines.